The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Express Scripts Holding Co

Nasdaq: ESRX
Last

(U.S.) $89.23

Today's change0.00 0.00%
Updated May 28 4:00 PM EDT. Delayed by at least 15 minutes.
 

Express Scripts Holding Co

Nasdaq: ESRX
Last

(U.S.) $89.23

Today's change0.00 0.00%
Updated May 28 4:00 PM EDT. Delayed by at least 15 minutes.

Express Scripts Holding Co closed at (U.S.)$89.23.

Shares have lost 1.08% over the last five days, but sit 2.17% below their 52-week high. This security has outperformed the S&P 500 by 14.47% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $89.23
  • High--
  • Low--
  • Bid / Ask(U.S.) $89.07 / (U.S.) $89.25
  • YTD % change+5.39%
  • Volume0
  • Average volume (10-day)4,404,803
  • Average volume (1-month)4,941,786
  • Average volume (3-month)3,913,497
  • 52-week range(U.S.) $65.08 to (U.S.) $91.21
  • Beta1.29
  • Trailing P/E31.41×
  • P/E 1 year forward16.40×
  • Forward PEG1.37×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.84
Updated May 28 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.00%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue24,90026,31325,77925,111
Total other revenue--------
Total revenue24,90026,31325,77925,111
Gross profit1,8342,2752,1382,116
Total cost of revenue23,06624,03823,64122,995
Total operating expense24,07325,37024,79424,145
Selling / general / administrative1,007950931912
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--383223238
Other operating expenses, total--------
Operating income827943984966
Interest income (expense), net non-operating-116-122-202-135
Gain (loss) on sale of assets--------
Other--------
Income before tax716831798842
Income after tax447589589523
Income tax, total268242209319
Net income441582582515
Total adjustments to net income--------
Net income before extra. items441582582515
Minority interest-6-7-7-8
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items441582582515
Inc. avail. to common incl. extra. items441582582515
Diluted net income441582582515
Dilution adjustment0------
Diluted weighted average shares735738746767
Diluted EPS excluding extraordinary itemsvalue per share0.600.790.780.67
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share0.601.161.000.87